מכפיל P/S עתידי: Zynex (ZYXI)

Zynex, Inc. (ZYXI) is protected by patents and FDA approval, which creates high barriers to entry for new players. This GURU.Markets forward price-to-sales chart illustrates a local trend where the value of 0.00 characterizes this level. The business relies on the closed-loop NexWave B2C cycle with high patient switching costs, while lifetime sales of electrostimulation consumables serve as a steady cash generator.

Zynex, Inc. (ZYXI) leverages electrotherapy automation and predictive monitoring to scale revenue by reducing the burden on medical personnel. By analyzing the projected P/S trend, investors assess the market value of the stock relative to expected annual sales volume, which helps determine the fairness of the asset's valuation and the risk of a "value trap" amid inflationary pressure on consumer demand.